LOZZI, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 15.918
EU - Europa 6.723
AS - Asia 3.816
SA - Sud America 653
AF - Africa 199
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 8
Totale 27.335
Nazione #
US - Stati Uniti d'America 15.819
CN - Cina 1.612
GB - Regno Unito 1.546
RU - Federazione Russa 1.319
SG - Singapore 1.036
IE - Irlanda 914
UA - Ucraina 626
SE - Svezia 572
BR - Brasile 530
DE - Germania 496
FR - Francia 402
IT - Italia 383
VN - Vietnam 327
HK - Hong Kong 275
KR - Corea 202
FI - Finlandia 201
ZA - Sudafrica 109
IN - India 97
ES - Italia 68
CA - Canada 50
AR - Argentina 47
BD - Bangladesh 40
BE - Belgio 34
NG - Nigeria 33
PL - Polonia 33
NL - Olanda 30
JP - Giappone 29
TR - Turchia 27
MX - Messico 24
IQ - Iraq 20
PK - Pakistan 20
CZ - Repubblica Ceca 18
RO - Romania 18
EC - Ecuador 17
AT - Austria 16
AU - Australia 16
IR - Iran 15
CI - Costa d'Avorio 14
JO - Giordania 14
VE - Venezuela 14
CO - Colombia 11
ID - Indonesia 11
PH - Filippine 11
PY - Paraguay 10
AZ - Azerbaigian 9
CL - Cile 9
IL - Israele 9
KE - Kenya 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
EU - Europa 8
MA - Marocco 8
NP - Nepal 8
TN - Tunisia 8
DZ - Algeria 6
KZ - Kazakistan 6
LB - Libano 6
LT - Lituania 6
PE - Perù 6
RS - Serbia 6
SA - Arabia Saudita 6
GR - Grecia 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
UZ - Uzbekistan 5
BY - Bielorussia 4
JM - Giamaica 4
UY - Uruguay 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KG - Kirghizistan 3
OM - Oman 3
SI - Slovenia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
EE - Estonia 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SV - El Salvador 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KW - Kuwait 1
Totale 27.327
Città #
Dallas 7.997
Southend 1.370
Dublin 907
Fairfield 799
Ashburn 628
Menlo Park 608
Singapore 583
Chandler 582
Jacksonville 489
Woodbridge 432
Moscow 355
Seattle 345
Santa Clara 344
Beijing 343
Wilmington 341
Houston 331
Ann Arbor 290
Cambridge 278
Hong Kong 270
Hefei 243
Seoul 201
Siena 197
San Jose 181
Nanjing 177
Princeton 167
The Dalles 110
Los Angeles 108
Johannesburg 105
Ho Chi Minh City 103
New York 93
Helsinki 87
Shanghai 84
Fremont 83
Lauterbourg 79
Boardman 77
Munich 73
Hanoi 71
San Mateo 69
Nanchang 67
Buffalo 61
São Paulo 51
Málaga 50
San Diego 50
Dong Ket 45
Dearborn 43
Shenyang 39
Council Bluffs 37
Orem 37
Abuja 33
Brussels 31
Changsha 30
Tianjin 30
Hebei 29
Redwood City 28
Turku 28
London 26
Warsaw 26
Toronto 24
Jiaxing 23
Bengaluru 22
Chennai 22
Kunming 22
Milan 21
Zhengzhou 21
Chicago 20
Frankfurt am Main 20
Jinan 20
Tokyo 20
San Francisco 19
Amsterdam 18
Washington 18
Columbus 16
Florence 16
Belo Horizonte 15
Guangzhou 15
Rio de Janeiro 15
University Park 15
Abidjan 14
Brasília 14
Brooklyn 14
Amman 13
Lancaster 13
Redondo Beach 13
Brno 12
Kansas City 12
Ningbo 12
Timisoara 12
Denver 11
Rome 11
Stockholm 11
Atlanta 10
Boston 10
Dhaka 10
Hangzhou 10
Hải Dương 10
Izmir 10
Manchester 10
Norwalk 10
Nürnberg 10
Paris 10
Totale 20.985
Nome #
1 H‐ and natural abundance 15 N‐nmr studies of a derivative of a rabies glycoprotein fragment 7.473
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 372
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 359
A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor 351
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 333
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 322
A model of the rabies virus glycoprotein active site 311
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 310
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 309
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 300
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 282
High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments 279
Tumor imaging with tetrabranched neurotensin 266
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 264
Affinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 259
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 257
Purification of acidic synthetic peptides by high performance liquid chromatography using ammonium acetate buffer 250
A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate camcer metastates, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2 246
Branched Neurotensin For Tumor Targeting 246
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 244
Bioactive peptides from libraries 241
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein 241
Antigenicity of HIV-derived T-helper determinants in the context of carrier recombinant proteins: effect on T-helper cell repertoire selection 237
Branched peptides as targeting agents for tumor imaging and therapy 236
Toxin-related antibodies with antimicrobial and antiviral activity 236
HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 231
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 231
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 228
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 227
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 224
Highly fluorescent protein labeling using dendritic peptide derivatives 223
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 221
Synthetic peptides in the form of dendrimers become resistant to protease activity 219
Antigenicity of synthetic peptides derived from C100 protein of hepatitis C virus 217
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 216
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 215
Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins 213
Single step purification of a synthetic peptide fragment of neurofilaments by preparative high performance liquid-chromatography 212
Dynein heavy chain related polypeptides in growing pollen tube of Nicotiana tabacum 210
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 209
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 207
The antimicrobial peptide M33. An example of drug development 206
CD and NMR structural characterization of ceratotoxins, natural peptides with antimicrobial activity 205
Branched neurotensin for tumor targeting 205
Interaction of Angiotensin II with the C-terminal 300-320 fragment of the rat Angiotensin II Receptor AT1a monitored by NMR 203
A novel mimetic antigen eliciting protective antibody to Neisseria Meningitidis 201
Tumor selective targeting by branched peptides 200
Binding of HIV-1 gp120 to the nicotinic receptor 199
Synthetic peptides of rubella E1 glycoprotein for serological assays 197
Molecular basis of branched peptides resistance to enzyme proteolysis 197
The 208-222 region of the peplomer glycoprotein putative binding site of the rabiesvirus with the nicotinic acetylcholine receptor 195
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 194
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 193
High molecular weight polypeptides related to dynein heavy chains in Nicotiana tabacum pollen tubes 192
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 191
Peptide-protein interactions studied by surface plasmon and nuclear magnetic resonances 188
Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides 185
Micro-determination of amino acid composition of proteins electroblotted onto polyvinylidene difluoride membranes 185
Surface Plasmon Resonance analysis of HIV-1 gp 120 binding to muscle nicotinic receptors 184
The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies 183
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 179
Structure and antigenic activity of rubella E1 glycoprotein synthetic peptides 178
Antigenic recognition of pertussis and cholera toxin by the same antipeptide antibodies 178
Epitopes identification by limited proteolysis 175
SNARE motif and neurotoxins 174
Synthetic antidotes against snake neurotoxins 173
Toxin-related antibodies with antimicrobial and antiviral activity 172
Selection of catalytically active biotin ligase and trypsin mutants by phage display 172
Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85 169
Recognition of CMV pp65 protein antigen by human CD4 T cell lines induced with an immunodominant peptide pool 168
The antimicrobial peptide M33. An example of drug development 167
Human T helper cells specific for HIV reverse transcriptase: possible role in intrastructural help for HIV envelope-specific antibodies 166
Multiple Antigen Peptides (MAP) as antidotes against snake neurotoxin intoxication 164
NMR and MD studies on the interaction between ligand peptides and alpha-bungarotoxin 164
Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution 162
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 161
Branched neurotensin peptides for tumor targeting 161
Tumor imaging with tetrabranched neurotensin 161
Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66 157
Dendrimeric peptides for tumor targeting 155
Synthesis and purification of site-specific peptide conjugated to bovine pancreatic trypsin inhibitor 154
NMR structure of alpha-bungarotoxin free and bound to a mimotope of the nicotinic acetylcholine receptor 152
Polipeptidi correlati alle catene pesanti delle dineine in tubetti pollinici di Nicotiana tabacum 152
Natural analogue peptides of an HIV-1 GP-120 T-helper epitope antagonize response of GP-120 specific human CD4 T-cell clones 147
Inhibition of experimental metastasis of murine fibrosarcoma cells by oligopeptide analogues to the fibronectin cell binding site 147
A strategy for isolation af catalytic activities from repertoires of enzymes displayed on phage 145
New Developments in Heterocyclic Silyl Enol Ether Chemistry: Synthesis and Lewis Acid Mediated Reactions with Carbon Electrophiles of 2,5-bis(trimethylsiloxy)thiophene and 1-Methyl-2,5-bis(trimethylsiloxy)pyrrole 141
Resolution of Conformational Equilibria In Linear Peptides By Circular-dichroism In Cryogenic Solvents 141
Histidyl tags and structural stabilization of linear peptides 140
Synthetic inhibitors of anthrax lethal toxin 139
Synthetic peptides in the form of dendrimers can become resistant to protease activity 139
Rational design and molecular diversity for the construction of anti-alpha-bungarotoxin antidotes with high affinity and in vivo efficiency 137
Recognition of human T-leukaemia virus (HTLV-1) envelope by human CD4+ - cell lines from HTLV-1 seronegative individuals: Specificity and clonal heterogeneity 131
NMR studies of the interaction of alpha-bungarotoxin with a mimotope of the nicotinic acetylcholine receptor 130
Structurally driven selection of human hepatitis C virus mimotopes. 124
On the structural stability of a small bioactive peptide of potential use in biotechnology 123
Role of manganese in MG-63 osteosarcoma cell attachment to fibrinogen and von Willabrand factor 119
STRONG SYNTHETIC INHIBITORS OF ANTHRAX LETHAL TOXIN 117
Rationally designed affinity maturation of a synthetic antidote against alpha-bungarotoxin 111
Peptides mimotopes of the nicotinic receptor binding site 99
Totale 27.474
Categoria #
all - tutte 64.985
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.985


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021416 0 0 0 0 0 0 0 0 0 135 151 130
2021/20221.223 76 175 86 136 58 29 51 61 44 125 116 266
2022/20232.010 122 209 246 294 205 394 26 171 183 71 72 17
2023/20241.344 36 50 143 70 50 391 472 16 3 15 10 88
2024/20252.536 65 141 270 137 293 131 70 131 200 86 282 730
2025/202612.604 487 2.663 5.945 828 1.179 243 579 204 230 246 0 0
Totale 27.474